当前位置: 首页 » 论文全文
←返回首页
期刊信息:
《药学服务与研究》2019年, 第19卷, 第3期, 第172-174,179页
标题:
外泌体的功能及其在肿瘤诊疗中的应用
DOI:
10.5428/pcar20190304
作者:
1. 鲁悦1(1.华东理工大学药学院 上海 200237 lory0310@163.com)
2. 戴琪1(1.华东理工大学药学院 上海 200237 )
3. 武鑫2(2.上海维洱实验室 上海 200433 )
4. 任福正1(1.华东理工大学药学院 上海 200237 fzren@ecust.edu.cn)
摘要:
摘要  外泌体广泛存在于各种体液中,是一种由细胞主动分泌的膜囊泡,直径为40~100 nm。外泌体中包含的生物大分子积极参与肿瘤细胞间的信息传递,参与并调控肿瘤的发生、发展。研究表明,将外泌体作为肿瘤检测的生物标记物是一种更加灵敏、准确的肿瘤诊断方法,且外泌体的结构和粒径赋予其天然的载药优势,是一种前景广阔的靶向药物载体。本文从外泌体的结构和功能入手,详细综述国内外关于外泌体在肿瘤靶向诊疗及药物传递系统开发中的研究进展。
欢迎阅读《药学服务与研究》!您是该文第 186 位读者!
若需在您的论文中引用此文,请按以下格式著录参考文献:
中文著录格式 鲁悦1,戴琪1,武鑫2,任福正1. 外泌体的功能及其在肿瘤诊疗中的应用[J]. 药学服务与研究. 2019; 19(3): 172-174,179.
英文著录格式 LU Yue1,DAI Qi1,WU Xin2,REN Fuzheng1. Function and application of exosomes in targeted diagnosis and treatment of tumors[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2019; 19(3): 172-174,179.
参考文献:
1. Johnstone R M,Adam M,Hammond J R,et al.Vesicle formation during reticulocyte maturation:association of plasma membrane activities with released vesicles(exosomes)[J].J Biol Chem,1987,262(19):9412-9420.
2. Pisitkun T,Shen R F,Knepper M A.Identification and proteomic profiling of exosomes in human urine[J].Proc Nat Acad Sci U S A,2004,101(36):13368-13373.
3. Ogawa Y,Miura Y,Harazono A,et al.Proteomic analysis of two types of exosomes in human whole saliva[J].Biol Pharm Bull,2011,34(1):13-23.
4. Caby M P,Lankar D,Vincendeau-Scherrer C,et al.Exosomal-like vesicles are present in human blood plasma[J].Int Immunol,2005,17(7):879-887.
5. Ailawadi S,WANG Xiaohong,GU Haitao,et al.Pathologic function and therapeutic potential of exosomes in cardiovascular disease[J].Biochim Biophys Acta,2015,1852(1):1-11.
6. Wollert T,Hurley J H.Molecular mechanism of multivesicular body biogenesis by ESCRT complexes[J].Nature,2010,464(7290):864-869.
7. Elmageed Z Y A,YANG Yijun,Thomas R,et al.Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes[J].Stem Cells,2014,32(4):983-997.
8. Kholia S,Ranghino A,Granieri P,et al.Extracellular vesicles as new players in angiogenesis[J].Vascul Pharmacol,2016,86(1):64-70.
9. Baroni S,Romero-Cordoba S,Plantamura I,et al.Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts[J].Cell Death Dis,2016,7(7):e2312.
10. Szajnik M,Czystowska M,Szczepanski M J,et al.Tumor-derived microvesicles induce,expand and up-regulate biological activities of human regulatory T cells(Treg)[J].PloS One,2010,5(7):e11469.
11. LI Yi,ZHANG Liqun,LIU Fei,et al.Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma[J].Dis Markers,2015,2015(9):893594.
12. Korzeniewski N,Tosev G,Pahernik S,et al.Identification of cell-free microRNAs in the urine of patients with prostate cancer[J].Urol Oncol,2015,33(1):16-17.
13. Madhavan B,YUE Shijing,Galli U,et al.Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity[J].Int J Cancer,2015,136(11):2616-2627.
14. FANG Jun,Nakamura H,Maeda H.The EPR effect:unique features of tumor blood vessels for drug delivery,factors involved,and limitations and augmentation of the effect[J].Adv Drug Deliv Rev,2011,63(3):136-151.
15. Pascucci L,Coccè V,Bonomi A,et al.Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth:a new approach for drug delivery[J].J Contr Release,2014,192(28):262-270.
16. TIAN Yanhua,LI Suping,SONG Jian,et al.A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy[J].Biomaterials,2014,35(7):2383-2390.
17. André F,Scharz N E C,Chaput N,et al.Tumor-derived exosomes:a new source of tumor rejection antigens[J].Vaccine,2002,20(4):A28-A31.
18. Morelli A E,Larregina A T,Shufesky W J,et al.Endocytosis,intracellular sorting,and processing of exosomes by dendritic cells[J].Blood,2004,104(10):3257-3266.
19. Hood J L,Roman S S,Wickline S A.Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis[J].Cancer Res,2011,71(11):3792-3801.
20. Ohno S,Takanashi M,Sudo K,et al.Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells[J].Mol Ther,2013,21(1):185-191.
21. Alvarez-Erviti L,Seow Y,YIN Haifeng,et al.Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes[J].Nat Biotechnol,2011,29(4):341-345.
22. Lee J,Lee H,Goh U,et al.Cellular engineering with membrane fusogenic liposomes to produce functionalized extracellular vesicles[J].Acs Appl Mat Interfaces,2016,8(11):6790-6795.
23. Kooijmans S A A,Fliervoet L A L,van der Meel R,et al.PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time[J].J Contr Release,2016,224(1):77-85.
24. QI Hongzhao,LIU Chaoyong,LONG Lixia,et al.Blood exosomes endowed with magnetic and targeting properties for cancer therapy[J].Acs Nano,2016,10(3):3323-3333.
25. Fabbri M,Paone A,Calore F,et al.MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response[J].Proc Natl Acad Sci U S A,2012,109(31):E2110-E2116.
26. Peinado H,Alecˇkovic M,Lavotshkin S,et al.Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET[J].Nat Med,2012,18(6):883-891.